Naari Pte Company Profile
What is the competitive landscape for NAARI PTE
NAARI PTE has eighteen approved drugs.
Summary for Naari Pte
| US Patents: | 0 |
| Tradenames: | 9 |
| Ingredients: | 8 |
| NDAs: | 18 |
Drugs and US Patents for Naari Pte
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Naari Pte | DESOGESTREL AND ETHINYL ESTRADIOL | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 209170-001 | Jun 5, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Naari Pte | NORGESTIMATE AND ETHINYL ESTRADIOL | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 203865-001 | Oct 27, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Naari Pte | LEVONORGESTREL | levonorgestrel | TABLET;ORAL | 207660-001 | May 2, 2019 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Naari Pte | DROSPIRENONE AND ETHINYL ESTRADIOL | drospirenone; ethinyl estradiol | TABLET;ORAL-28 | 207245-001 | Nov 22, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
